Whole genome and whole exome sequencing (WGS/WES) technologies promise to revolutionise health care. However these disruptive technologies are likely to result in significant changes in the process of diagnosis and treatment and in clinician: patient interaction.
In this new project we aim to identify some of the ethical, legal and social issues these technologies present. We will consider the implications for clinicians, the impact upon patients and on health services, policy makers and regulators. We will use our findings to make recommendations for tackling some of the challenges of implementing genomic technologies in clinical care in the NHS.